BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of investors of NantKwest, Inc. (“NantKwest” or the “Company”) (NASDAQ: NK) concerning the Company and its officers’ possible violations of federal securities laws. Law Offices of Howard G. Smith is preparing a lawsuit on behalf of injured investors.
NantKwest is a biotechnology company that develops immunotherapeutic agents for various clinical conditions.
Specifically, the investigation concerns NantKwest’s March 11, 2016 announcement that the Company's interim financial statements for the quarters ended June 30, 2015 and September 30, 2015 should not be relied upon due to financial statement errors in connection with certain stock-based awards.
On this news, shares of NantKwest fell over 3% on March 11, 2016, closing at just $8.17 per share.
If you purchased NantKwest securities, including certain options and debt instruments, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to firstname.lastname@example.org, or visit our website at http://www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.